𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of polo-like-kinase-1 is as efficient for the treatment of pancreatic adenocarcinoma as treatment with capecitabine

✍ Scribed by Teller, S.; Sendler, M.; Dummer, A.; Partecke, L.-I.; Weiss, F.-U.; Lerch, M.M.; Mayerle, J.

Book ID
123518566
Publisher
S. Karger AG
Year
2013
Tongue
English
Weight
44 KB
Volume
13
Category
Article
ISSN
1424-3903

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multicentric parallel phase II trial of
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
✍ Patrick SchΓΆffski; Jean-Yves Blay; Jacques De Greve; Etienne Brain; Jean-Pascal πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 657 KB
1260 Multicenter parallel phase II trial
1260 Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
✍ P. SchΓΆffski; J.Y. Blay; J. DeGreve; E. Brain; J.P. Machiels; J.C. Soria; S. Sle πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 67 KB
P.39 Docetaxel plus epirubicin (DE) vs d
P.39 Docetaxel plus epirubicin (DE) vs docetaxel plus capecitabine (DC) as 1st line treatment in patients with locally advanced and metastatic breast cancer: a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)
✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 57 KB